SCHEMBL13929909

SCHEMBL13929909

COC(=O)[C@@]1(C)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@@]21C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 12/20 0.66
PGR P06401 6/20 0.66
HIF1A Q16665 5/20 0.66
HSD17B10 Q99714 2/20 0.66
ABCB11 O95342 2/20 0.66
CYP3A4 P08684 2/20 0.66
TNF P01375 1/20 0.66
IL6 P05231 1/20 0.66
SERPINA6 P08185 1/20 0.66
NR3C2 P08235 1/20 0.66
AR P10275 1/20 0.66
GLUL P15104 1/20 0.66
ADAM17 P78536 1/20 0.66
GPBAR1 Q8TDU6 1/20 0.66
CYP2C19 P33261 1/20 0.66
NR1I2 O75469 2/20 0.60
ABCC3 O15438 1/20 0.60
LMNA P02545 4/20 0.57
CNR1 P21554 1/20 0.57
USP2 O75604 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1685803 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL5098329 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL15796471 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL12969465 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL13379819 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL12738238 0.89 NR3C1 (0.76) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL9456280 0.88 NR3C1 (0.65) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL24622279 0.86 NR3C1 (0.80) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL22456877 0.86 NR3C1 (0.80) NR3C1PGRHIF1AHSD17B10ABCB11
SCHEMBL12212096 0.86 NR3C1 (0.80) NR3C1PGRHIF1AHSD17B10ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048221-A1 Conjugates with Anti-Inflammatory Activity GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048221-A1 Conjugates with Anti-Inflammatory Activity MPO, EPX, NOD1 NR3C1 237/4885PGR 643/4885HIF1A 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.